PUBLISHER: TechNavio | PRODUCT CODE: 2126086
PUBLISHER: TechNavio | PRODUCT CODE: 2126086
Global Cardiac Prosthetic Devices Market 2026-2030
The global cardiac prosthetic devices market is forecasted to grow by USD 6175.1 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global cardiac prosthetic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of valvular and structural heart disorders, advancing transcatheter and minimally-invasive cardiac technologies, expanding healthcare infrastructure and cardiac care accessibility.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7% |
| CAGR | 7.5% |
| Incremental Value | $6175.1 mn |
Technavio's global cardiac prosthetic devices market is segmented as below:
By Product
- Prosthetic heart valves
- Implantable pacemakers
By Material
- Metal alloys
- Biological tissue
- Polymeric and hybrid materials
By End-User
- Hospitals
- Cardiac centers
- Specialty clinics
- Ambulatory surgical centers (ASCs)
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expanding lifetime valve management strategies as one of the prime reasons driving the global cardiac prosthetic devices market growth during the next few years. Also, evolving patient-specific prosthetic selection approaches and scaling integration of digital monitoring and follow-up pathways will lead to sizable demand in the market.
The report on the global cardiac prosthetic devices market covers the following areas:
- Global cardiac prosthetic devices market sizing
- Global cardiac prosthetic devices market forecast
- Global cardiac prosthetic devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cardiac prosthetic devices market vendors that include Abbott Laboratories, Artivion Inc., Becton Dickinson and Co., Berlin Heart GmbH, BIOTRONIK SE and Co. KG, Boston Scientific Corp., Cook Medical LLC, Corcym Srl, Edwards Lifesciences Corp., Getinge AB, Johnson and Johnson MedTech, Lepu Medical Co. Ltd., Lifetech Scientific Corp., LivaNova PLC, Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Peijia Medical Ltd., Teleflex Inc., Terumo Corp., Venus Medtech Hangzhou Inc., W. L. Gore and Associates Inc.. Also, the global cardiac prosthetic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Material
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cardiac Prosthetic Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Cardiac Prosthetic Devices Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 Material segment analysis 2020 - 2024
- Historic Market Size - Material Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global cardiac prosthetic devices market
- 6.2 Impact of geopolitical conflicts on global cardiac prosthetic devices market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Prosthetic heart valves - Market size and forecast 2025-2030
- 8.4 Implantable pacemakers - Market size and forecast 2025-2030
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Material
- 9.1 Market segments
- 9.2 Comparison by Material
- 9.3 Metal alloys - Market size and forecast 2025-2030
- 9.4 Biological tissue - Market size and forecast 2025-2030
- 9.5 Polymeric and hybrid materials - Market size and forecast 2025-2030
- 9.6 Market opportunity by Material
- Market opportunity by Material ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- 10.4 Cardiac centers - Market size and forecast 2025-2030
- 10.5 Specialty clinics - Market size and forecast 2025-2030
- 10.6 Ambulatory surgical centers (ASCs) - Market size and forecast 2025-2030
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 Argentina - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 Israel - Market size and forecast 2025-2030
- 12.6.8 Turkey - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing prevalence of valvular and structural heart disorders
- Advancing transcatheter and minimally-invasive cardiac technologies
- Expanding healthcare infrastructure and cardiac care accessibility
- 13.2 Market challenges
- High procedural complexity and specialist dependency
- Stringent regulatory and compliance requirements
- Limited affordability and reimbursement variability
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expanding lifetime valve management strategies
- Evolving patient-specific prosthetic selection approaches
- Scaling integration of digital monitoring and follow-up pathways
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 BIOTRONIK SE and Co. KG
- BIOTRONIK SE and Co. KG - Overview
- BIOTRONIK SE and Co. KG - Product / Service
- BIOTRONIK SE and Co. KG - Key offerings
- SWOT
- 15.6 Boston Scientific Corp.
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
- 15.7 Cook Medical LLC
- Cook Medical LLC - Overview
- Cook Medical LLC - Product / Service
- Cook Medical LLC - Key offerings
- SWOT
- 15.8 Edwards Lifesciences Corp.
- Edwards Lifesciences Corp. - Overview
- Edwards Lifesciences Corp. - Business segments
- Edwards Lifesciences Corp. - Key news
- Edwards Lifesciences Corp. - Key offerings
- Edwards Lifesciences Corp. - Segment focus
- SWOT
- 15.9 Getinge AB
- Getinge AB - Overview
- Getinge AB - Business segments
- Getinge AB - Key offerings
- Getinge AB - Segment focus
- SWOT
- 15.10 Johnson and Johnson MedTech
- Johnson and Johnson MedTech - Overview
- Johnson and Johnson MedTech - Product / Service
- Johnson and Johnson MedTech - Key offerings
- SWOT
- 15.11 Lepu Medical Co. Ltd.
- Lepu Medical Co. Ltd. - Overview
- Lepu Medical Co. Ltd. - Product / Service
- Lepu Medical Co. Ltd. - Key offerings
- SWOT
- 15.12 LivaNova PLC
- LivaNova PLC - Overview
- LivaNova PLC - Business segments
- LivaNova PLC - Key offerings
- LivaNova PLC - Segment focus
- SWOT
- 15.13 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.14 Meril Life Sciences Pvt. Ltd.
- Meril Life Sciences Pvt. Ltd. - Overview
- Meril Life Sciences Pvt. Ltd. - Product / Service
- Meril Life Sciences Pvt. Ltd. - Key offerings
- SWOT
- 15.15 MicroPort Scientific Corp.
- MicroPort Scientific Corp. - Overview
- MicroPort Scientific Corp. - Business segments
- MicroPort Scientific Corp. - Key offerings
- MicroPort Scientific Corp. - Segment focus
- SWOT
- 15.16 Teleflex Inc.
- Teleflex Inc. - Overview
- Teleflex Inc. - Business segments
- Teleflex Inc. - Key news
- Teleflex Inc. - Key offerings
- Teleflex Inc. - Segment focus
- SWOT
- 15.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
- 15.18 W. L. Gore and Associates Inc.
- W. L. Gore and Associates Inc. - Overview
- W. L. Gore and Associates Inc. - Product / Service
- W. L. Gore and Associates Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
